Comment
. 2005 Mar 31;352(13):1386; author reply 1386.
doi: 10.1056/NEJM200503313521324.
Levodopa and the progression of Parkinson's disease
- PMID: 15800240
- DOI: 10.1056/NEJM200503313521324
Item in Clipboard
Comment
Levodopa and the progression of Parkinson's disease
N Engl J Med.
.
No abstract available
Comment on
-
Levodopa and the progression of Parkinson's disease.N Engl J Med. 2004 Dec 9;351(24):2498-508. doi: 10.1056/NEJMoa033447. N Engl J Med. 2004. PMID: 15590952 Clinical Trial.
Similar articles
-
The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease.Ann Neurol. 2001 Mar;49(3):285-7. Ann Neurol. 2001. PMID: 11261500 No abstract available.
-
Pharmacokinetics and pharmacodynamics of levodopa.Mov Disord. 2008;23 Suppl 3:S580-4. doi: 10.1002/mds.22037. Mov Disord. 2008. PMID: 18781675 Review.
-
Levodopa for Parkinson's disease.N Engl J Med. 2009 Feb 26;360(9):936; author reply 936. N Engl J Med. 2009. PMID: 19256032 No abstract available.
-
Levodopa in Parkinson's disease: from the past to the future.Expert Opin Pharmacother. 2010 Mar;11(4):627-35. doi: 10.1517/14656561003598919. Expert Opin Pharmacother. 2010. PMID: 20163273 Review.
-
Levodopa-related motor complications--phenomenology.Mov Disord. 2008;23 Suppl 3:S509-14. doi: 10.1002/mds.22021. Mov Disord. 2008. PMID: 18781677 Review.
Cited by
-
Targeting the progression of Parkinson's disease.Curr Neuropharmacol. 2009 Mar;7(1):9-36. doi: 10.2174/157015909787602814. Curr Neuropharmacol. 2009. PMID: 19721815 Free PMC article.
-
Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome.Sci Rep. 2023 Sep 12;13(1):15069. doi: 10.1038/s41598-023-42135-9. Sci Rep. 2023. PMID: 37700061 Free PMC article.
-
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.Brain Pathol. 2022 May;32(3):e13012. doi: 10.1111/bpa.13012. Epub 2021 Aug 20. Brain Pathol. 2022. PMID: 34414627 Free PMC article. Review.
-
The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease.Transl Neurodegener. 2016 Jun 30;5:12. doi: 10.1186/s40035-016-0059-z. eCollection 2016. Transl Neurodegener. 2016. PMID: 27366321 Free PMC article. Review.
-
Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD).Neurotherapeutics. 2020 Oct;17(4):1331-1338. doi: 10.1007/s13311-020-00924-4. Epub 2020 Sep 15. Neurotherapeutics. 2020. PMID: 32935299 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
